Medical - Distribution
Compare Stocks
5 / 10Stock Comparison
HSIC vs DBVT vs ALKS vs DXPE vs PRGO
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Biotechnology
Industrial - Distribution
Drug Manufacturers - Specialty & Generic
HSIC vs DBVT vs ALKS vs DXPE vs PRGO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Distribution | Biotechnology | Biotechnology | Industrial - Distribution | Drug Manufacturers - Specialty & Generic |
| Market Cap | $8.13B | $1690.08T | $5.83B | $2.42B | $1.62B |
| Revenue (TTM) | $13.18B | $0.00 | $1.56B | $2.06B | $4.18B |
| Net Income (TTM) | $398M | $-168M | $153M | $88M | $-1.82B |
| Gross Margin | 29.1% | — | 65.4% | 31.7% | 34.2% |
| Operating Margin | 5.8% | — | 12.3% | 8.7% | -4.1% |
| Forward P/E | 13.2x | — | 24.5x | 25.5x | 5.5x |
| Total Debt | $3.69B | $22M | $70M | $982M | $3.97B |
| Cash & Equiv. | $156M | $194M | $1.12B | $304M | $532M |
HSIC vs DBVT vs ALKS vs DXPE vs PRGO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Henry Schein, Inc. (HSIC) | 100 | 116.6 | +16.6% |
| DBV Technologies S.… (DBVT) | 100 | 40.7 | -59.3% |
| Alkermes plc (ALKS) | 100 | 213.9 | +113.9% |
| DXP Enterprises, In… (DXPE) | 100 | 885.9 | +785.9% |
| Perrigo Company plc (PRGO) | 100 | 21.4 | -78.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HSIC vs DBVT vs ALKS vs DXPE vs PRGO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HSIC ranks third and is worth considering specifically for stability.
- Beta 0.72 vs DXPE's 1.70, lower leverage
DBVT is the clearest fit if your priority is momentum.
- +100.5% vs PRGO's -52.0%
ALKS is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.00, Low D/E 3.8%, current ratio 3.55x
- 9.8% margin vs PRGO's -43.5%
DXPE has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 11.9%, EPS growth 27.0%, 3Y rev CAGR 10.8%
- 7.3% 10Y total return vs HSIC's 5.8%
- 11.9% revenue growth vs DBVT's -100.0%
- 5.6% ROA vs DBVT's -89.0%
PRGO is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 10 yrs, beta 1.21, yield 9.8%
- Beta 1.21, yield 9.8%, current ratio 2.76x
- Lower P/E (5.5x vs 25.5x)
- 9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.9% revenue growth vs DBVT's -100.0% | |
| Value | Lower P/E (5.5x vs 25.5x) | |
| Quality / Margins | 9.8% margin vs PRGO's -43.5% | |
| Stability / Safety | Beta 0.72 vs DXPE's 1.70, lower leverage | |
| Dividends | 9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +100.5% vs PRGO's -52.0% | |
| Efficiency (ROA) | 5.6% ROA vs DBVT's -89.0% |
HSIC vs DBVT vs ALKS vs DXPE vs PRGO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HSIC vs DBVT vs ALKS vs DXPE vs PRGO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ALKS leads in 2 of 6 categories
PRGO leads 2 • DXPE leads 1 • HSIC leads 0 • DBVT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ALKS leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HSIC and DBVT operate at a comparable scale, with $13.2B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $13.2B | $0 | $1.6B | $2.1B | $4.2B |
| EBITDAEarnings before interest/tax | $1.1B | -$112M | $212M | $209M | $58M |
| Net IncomeAfter-tax profit | $398M | -$168M | $153M | $88M | -$1.8B |
| Free Cash FlowCash after capex | $561M | -$151M | $392M | $71M | $108M |
| Gross MarginGross profit ÷ Revenue | +29.1% | — | +65.4% | +31.7% | +34.2% |
| Operating MarginEBIT ÷ Revenue | +5.8% | — | +12.3% | +8.7% | -4.1% |
| Net MarginNet income ÷ Revenue | +3.0% | — | +9.8% | +4.3% | -43.5% |
| FCF MarginFCF ÷ Revenue | +4.3% | — | +25.1% | +3.4% | +2.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.7% | — | +28.2% | +9.5% | -7.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +14.9% | +91.5% | -4.1% | -2.4% | -56.4% |
Valuation Metrics
PRGO leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 21.7x trailing earnings, HSIC trades at a 26% valuation discount to DXPE's 29.1x P/E. On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than ALKS's 17.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $8.1B | $1690.08T | $5.8B | $2.4B | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $11.7B | $1690.08T | $4.8B | $3.1B | $5.1B |
| Trailing P/EPrice ÷ TTM EPS | 21.66x | -0.75x | 24.47x | 29.14x | -1.14x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.25x | — | — | 25.52x | 5.53x |
| PEG RatioP/E ÷ EPS growth rate | 6.87x | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 10.90x | — | 17.01x | 14.38x | 7.43x |
| Price / SalesMarket cap ÷ Revenue | 0.62x | — | 3.95x | 1.20x | 0.38x |
| Price / BookPrice ÷ Book value/share | 1.80x | 0.65x | 3.25x | 5.15x | 0.55x |
| Price / FCFMarket cap ÷ FCF | 14.18x | — | 12.14x | 44.91x | 11.17x |
Profitability & Efficiency
ALKS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DXPE delivers a 17.9% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to DXPE's 1.97x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs PRGO's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.2% | -130.2% | +8.8% | +17.9% | -50.7% |
| ROA (TTM)Return on assets | +3.6% | -89.0% | +5.4% | +5.6% | -19.8% |
| ROICReturn on invested capital | +7.1% | — | +18.9% | +12.5% | +3.7% |
| ROCEReturn on capital employed | +9.8% | -145.7% | +14.2% | +14.0% | +4.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 7 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.77x | 0.13x | 0.04x | 1.97x | 1.35x |
| Net DebtTotal debt minus cash | $3.5B | -$172M | -$1.0B | $678M | $3.4B |
| Cash & Equiv.Liquid assets | $156M | $194M | $1.1B | $304M | $532M |
| Total DebtShort + long-term debt | $3.7B | $22M | $70M | $982M | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | 4.59x | -189.82x | 32.30x | 2.89x | -7.20x |
Total Returns (Dividends Reinvested)
DXPE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DXPE five years ago would be worth $48,898 today (with dividends reinvested), compared to $3,172 for DBVT. Over the past 12 months, DBVT leads with a +100.5% total return vs PRGO's -52.0%. The 3-year compound annual growth rate (CAGR) favors DXPE at 85.5% vs PRGO's -25.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -7.8% | +3.6% | +23.8% | +45.0% | -13.6% |
| 1-Year ReturnPast 12 months | +2.8% | +100.5% | +15.2% | +80.6% | -52.0% |
| 3-Year ReturnCumulative with dividends | -11.3% | +18.1% | +13.2% | +538.5% | -58.1% |
| 5-Year ReturnCumulative with dividends | -14.6% | -68.3% | +61.7% | +389.0% | -60.3% |
| 10-Year ReturnCumulative with dividends | +5.8% | -87.1% | -12.0% | +732.1% | -77.7% |
| CAGR (3Y)Annualised 3-year return | -3.9% | +5.7% | +4.2% | +85.5% | -25.2% |
Risk & Volatility
Evenly matched — HSIC and ALKS each lead in 1 of 2 comparable metrics.
Risk & Volatility
HSIC is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than DXPE's 1.70 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 95.6% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 1.26x | 1.00x | 1.70x | 1.21x |
| 52-Week HighHighest price in past year | $89.29 | $26.18 | $36.60 | $183.76 | $28.44 |
| 52-Week LowLowest price in past year | $61.95 | $7.53 | $25.17 | $75.58 | $9.23 |
| % of 52W HighCurrent price vs 52-week peak | +79.3% | +75.3% | +95.6% | +85.0% | +41.2% |
| RSI (14)Momentum oscillator 0–100 | 34.3 | 47.4 | 60.5 | 42.7 | 53.1 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 252K | 2.2M | 175K | 3.3M |
Analyst Outlook
PRGO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HSIC as "Hold", DBVT as "Buy", ALKS as "Buy", DXPE as "Hold", PRGO as "Hold". Consensus price targets imply 209.1% upside for PRGO (target: $36) vs -1.4% for DXPE (target: $154). PRGO is the only dividend payer here at 9.82% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $85.43 | $46.33 | $46.00 | $154.00 | $36.20 |
| # AnalystsCovering analysts | 32 | 15 | 28 | 7 | 36 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.0% | +9.8% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 0 | 4 | 10 |
| Dividend / ShareAnnual DPS | — | — | — | $0.01 | $1.15 |
| Buyback YieldShare repurchases ÷ mkt cap | +10.5% | 0.0% | +0.5% | +0.7% | 0.0% |
ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
HSIC vs DBVT vs ALKS vs DXPE vs PRGO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HSIC or DBVT or ALKS or DXPE or PRGO a better buy right now?
For growth investors, DXP Enterprises, Inc.
(DXPE) is the stronger pick with 11. 9% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 7x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HSIC or DBVT or ALKS or DXPE or PRGO?
On trailing P/E, Henry Schein, Inc.
(HSIC) is the cheapest at 21. 7x versus DXP Enterprises, Inc. at 29. 1x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — HSIC or DBVT or ALKS or DXPE or PRGO?
Over the past 5 years, DXP Enterprises, Inc.
(DXPE) delivered a total return of +389. 0%, compared to -68. 3% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: DXPE returned +732. 1% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HSIC or DBVT or ALKS or DXPE or PRGO?
By beta (market sensitivity over 5 years), Henry Schein, Inc.
(HSIC) is the lower-risk stock at 0. 72β versus DXP Enterprises, Inc. 's 1. 70β — meaning DXPE is approximately 134% more volatile than HSIC relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 197% for DXP Enterprises, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HSIC or DBVT or ALKS or DXPE or PRGO?
By revenue growth (latest reported year), DXP Enterprises, Inc.
(DXPE) is pulling ahead at 11. 9% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: DXP Enterprises, Inc. grew EPS 27. 0% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, DXPE leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HSIC or DBVT or ALKS or DXPE or PRGO?
Alkermes plc (ALKS) is the more profitable company, earning 16.
4% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HSIC or DBVT or ALKS or DXPE or PRGO more undervalued right now?
On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.
5x forward P/E versus 25. 5x for DXP Enterprises, Inc. — 20. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 209. 1% to $36. 20.
08Which pays a better dividend — HSIC or DBVT or ALKS or DXPE or PRGO?
In this comparison, PRGO (9.
8% yield) pays a dividend. HSIC, DBVT, ALKS, DXPE do not pay a meaningful dividend and should not be held primarily for income.
09Is HSIC or DBVT or ALKS or DXPE or PRGO better for a retirement portfolio?
For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
21), 9. 8% yield). Both have compounded well over 10 years (PRGO: -77. 7%, DBVT: -87. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HSIC and DBVT and ALKS and DXPE and PRGO?
These companies operate in different sectors (HSIC (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and DXPE (Industrials) and PRGO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HSIC is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; DXPE is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while HSIC, DBVT, ALKS, DXPE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.